BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,601,384 | +1.6% | 649,913 | +1.1% | 0.00% | +100.0% |
| Q2 2023 | $4,526,981 | +62.3% | 643,037 | +92.3% | 0.00% | 0.0% |
| Q1 2023 | $2,788,804 | -70.8% | 334,389 | -59.8% | 0.00% | -66.7% |
| Q4 2022 | $9,555,000 | +46.2% | 832,325 | +60.5% | 0.00% | +50.0% |
| Q3 2022 | $6,535,000 | +148.8% | 518,702 | +108.9% | 0.00% | +100.0% |
| Q2 2022 | $2,627,000 | +20.3% | 248,283 | +85.0% | 0.00% | 0.0% |
| Q1 2022 | $2,183,000 | +190.7% | 134,228 | +182.7% | 0.00% | – |
| Q2 2021 | $751,000 | +46.7% | 47,483 | -5.7% | 0.00% | – |
| Q1 2021 | $512,000 | -2.5% | 50,334 | -28.7% | 0.00% | – |
| Q4 2020 | $525,000 | +201.7% | 70,574 | +39.4% | 0.00% | – |
| Q3 2020 | $174,000 | -54.3% | 50,624 | -36.7% | 0.00% | – |
| Q2 2020 | $381,000 | +1.1% | 79,966 | -26.6% | 0.00% | – |
| Q4 2019 | $377,000 | +50.8% | 109,019 | +25.0% | 0.00% | – |
| Q3 2019 | $250,000 | -73.8% | 87,250 | -26.2% | 0.00% | – |
| Q4 2018 | $954,000 | – | 118,223 | +393976.7% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 30 | -99.0% | 0.00% | – |
| Q3 2013 | $22,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |